{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T14:06:27Z","timestamp":1771855587701,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974032"],"award-info":[{"award-number":["81974032"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nitric Oxide"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.niox.2025.12.003","type":"journal-article","created":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T07:01:03Z","timestamp":1766905263000},"page":"9-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Therapeutic potential of S-nitroso-l-cysteine in improving cardiorenal function in eNOS-KO CKD mice"],"prefix":"10.1016","volume":"161","author":[{"given":"Xiaofan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahe","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwen","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuntai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.niox.2025.12.003_bib1","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1159\/000528560","article-title":"Cardiovascular risk prediction in chronic kidney disease","volume":"53","author":"Li","year":"2022","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.niox.2025.12.003_bib2","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ki.2010.536","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts","volume":"79","author":"van der Velde","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.niox.2025.12.003_bib3","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American heart association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2025.12.003_bib4","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/CIRCRESAHA.123.321752","article-title":"Endothelial cell dysfunction and increased cardiovascular risk in patients with chronic kidney disease","volume":"132","author":"Baaten","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.niox.2025.12.003_bib5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrcardio.2017.224","article-title":"Nitric oxide signalling in cardiovascular health and disease","volume":"15","author":"Farah","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.niox.2025.12.003_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010531","article-title":"Impact of uremic toxins on endothelial dysfunction in chronic kidney disease: a systematic review","volume":"23","author":"Harlacher","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.niox.2025.12.003_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00018-005-5421-8","article-title":"Endothelial nitric oxide synthase: insight into cell-specific gene regulation in the vascular endothelium","volume":"63","author":"Fish","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.niox.2025.12.003_bib8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.freeradbiomed.2025.04.015","article-title":"Intermedin protects peritubular capillaries by inhibiting eNOS uncoupling through AMPK\/GTPCH-I\/BH4 pathway and alleviate CKD following AKI","volume":"234","author":"Lin","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.niox.2025.12.003_bib9","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehu111","article-title":"Carbamylated low-density lipoprotein induces endothelial dysfunction","volume":"35","author":"Speer","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.niox.2025.12.003_bib10","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/HJH.0b013e32833992ef","article-title":"Interleukin-6 inhibits endothelial nitric oxide synthase activation and increases endothelial nitric oxide synthase binding to stabilized caveolin-1 in human vascular endothelial cells","volume":"28","author":"Hung","year":"2010","journal-title":"J. Hypertens."},{"key":"10.1016\/j.niox.2025.12.003_bib11","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/01.CIR.0000033116.22237.F9","article-title":"Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells","volume":"106","author":"Venugopal","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2025.12.003_bib12","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00467-018-4005-4","article-title":"Oxidative stress in chronic kidney disease","volume":"34","author":"Daenen","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.niox.2025.12.003_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810659","article-title":"Effects of chronic kidney disease on nanomechanics of the endothelial glycocalyx are mediated by the mineralocorticoid receptor","volume":"23","author":"Fels","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.niox.2025.12.003_bib14","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101919R","article-title":"Endothelial dysfunction aggravates arterial media calcification in warfarin administered rats","volume":"36","author":"Van den Bergh","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.niox.2025.12.003_bib15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1471-4914(03)00028-5","article-title":"S-nitrosylation in health and disease","volume":"9","author":"Foster","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.niox.2025.12.003_bib16","doi-asserted-by":"crossref","first-page":"20102","DOI":"10.1074\/jbc.M413164200","article-title":"Identification of stereoselective transporters for S-nitroso-L-cysteine: role of LAT1 and LAT2 in biological activity of S-nitrosothiols","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.niox.2025.12.003_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/35093117","article-title":"S-nitrosothiols signal the ventilatory response to hypoxia","volume":"413","author":"Lipton","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.niox.2025.12.003_bib18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/01.RES.79.2.256","article-title":"Hemodynamic effects of L- and D-S-nitrosocysteine in the rat. Stereoselective S-nitrosothiol recognition sites","volume":"79","author":"Davisson","year":"1996","journal-title":"Circ. Res."},{"key":"10.1016\/j.niox.2025.12.003_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.134174","article-title":"Voltage-gated potassium channel proteins and stereoselective S-nitroso-l-cysteine signaling","volume":"5","author":"Gaston","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.niox.2025.12.003_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.892307","article-title":"S-Nitroso-L-Cysteine stereoselectively blunts the deleterious effects of fentanyl on breathing while augmenting antinociception in freely-moving rats","volume":"13","author":"Getsy","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.niox.2025.12.003_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78107-6","article-title":"NADPH diaphorase detects S-nitrosylated proteins in aldehyde-treated biological tissues","volume":"10","author":"Seckler","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.niox.2025.12.003_bib22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev-physiol-021113-170352","article-title":"Nitrogen chemistry and lung physiology","volume":"77","author":"Marozkina","year":"2015","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.niox.2025.12.003_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110229","article-title":"Functional evidence that S-nitroso-L-cysteine may be a candidate carotid body neurotransmitter","volume":"265","author":"Getsy","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.niox.2025.12.003_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.tips.2015.10.002","article-title":"Protein S-Nitrosylation as a therapeutic target for neurodegenerative diseases","volume":"37","author":"Nakamura","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.niox.2025.12.003_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1011383","article-title":"Myocardial protection of S-nitroso-L-cysteine in diabetic cardiomyopathy mice","volume":"13","author":"Peng","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.niox.2025.12.003_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/biom15030364","article-title":"ACAA2 protects against cardiac dysfunction and lipid peroxidation in renal insufficiency with the treatment of S-Nitroso-L-Cysteine","volume":"15","author":"Xu","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.niox.2025.12.003_bib27","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/cvr\/cvad083","article-title":"Cardiovascular complications in chronic kidney disease: a review from the European renal and cardiovascular medicine working group of the european renal association","volume":"119","author":"Zoccali","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.niox.2025.12.003_bib28","doi-asserted-by":"crossref","first-page":"F275","DOI":"10.1152\/ajprenal.00020.2019","article-title":"Reduced endothelial nitric oxide synthase activation contributes to cardiovascular injury during chronic kidney disease progression","volume":"317","author":"Amador-Martinez","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.niox.2025.12.003_bib29","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41440-022-01141-6","article-title":"Endothelial function, arterial stiffness and Framingham risk score in chronic kidney disease: a prospective observational cohort study","volume":"46","author":"Li","year":"2023","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.niox.2025.12.003_bib30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/ndt\/gfaa335","article-title":"Effect of fructooligosaccharide on endothelial function in CKD patients: a randomized controlled trial","volume":"37","author":"Armani","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.niox.2025.12.003_bib31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2215\/CJN.0000000000000337","article-title":"Effect of resveratrol on endothelial function in patients with CKD and diabetes: a randomized controlled trial","volume":"19","author":"Gimblet","year":"2024","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.niox.2025.12.003_bib32","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1152\/japplphysiol.00808.2021","article-title":"Aerobic exercise training improves endothelial function and attenuates blood pressure reactivity during maximal exercise in chronic kidney disease","volume":"132","author":"Sprick","year":"2022","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.niox.2025.12.003_bib33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11883-025-01290-2","article-title":"Managing dyslipidemia in chronic kidney disease: implications for cardiovascular and renal risk","volume":"27","author":"Theofilis","year":"2025","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.niox.2025.12.003_bib34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1523-1755.2003.00702.x","article-title":"Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency","volume":"63","author":"Vaziri","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.niox.2025.12.003_bib35","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1159\/000475890","article-title":"Targeting the KEAP1-NRF2 system to prevent kidney disease progression","volume":"45","author":"Nezu","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.niox.2025.12.003_bib36","doi-asserted-by":"crossref","first-page":"183","DOI":"10.23876\/j.krcp.20.163","article-title":"Implications of oxidative stress in chronic kidney disease: a review on current concepts and therapies","volume":"40","author":"Verma","year":"2021","journal-title":"Kidney Res. Clin. Pract."},{"key":"10.1016\/j.niox.2025.12.003_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13060687","article-title":"Role of uremic toxins, oxidative stress, and renal fibrosis in chronic kidney disease","volume":"13","author":"Frak","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.niox.2025.12.003_bib38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00109-021-02037-7","article-title":"Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches","volume":"99","author":"Dusing","year":"2021","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.niox.2025.12.003_bib39","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(00)02783-5","article-title":"Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial","volume":"356","author":"Boaz","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.niox.2025.12.003_bib40","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.CIR.0000050628.11305.30","article-title":"The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial","volume":"107","author":"Tepel","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2025.12.003_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13060751","article-title":"Potentials of natural antioxidants in reducing inflammation and oxidative stress in chronic kidney disease","volume":"13","author":"Lee","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.niox.2025.12.003_bib42","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2025.12.003_bib43","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/1440-1681.13556","article-title":"Renal lipotoxicity: insights from experimental models","volume":"48","author":"Castro","year":"2021","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.niox.2025.12.003_bib44","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","article-title":"Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease","volume":"19","author":"Mitrofanova","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.niox.2025.12.003_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.119146","article-title":"The vicious circle of chronic kidney disease and hypertriglyceridemia: what is first, the hen or the egg?","volume":"403","author":"Tramontano","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.niox.2025.12.003_bib46","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3389\/fphys.2020.00732","article-title":"The vicious cycle of renal lipotoxicity and mitochondrial dysfunction","volume":"11","author":"Ge","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.niox.2025.12.003_bib47","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1194\/jlr.P040501","article-title":"Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy","volume":"55","author":"Herman-Edelstein","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.niox.2025.12.003_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/nu13093138","article-title":"Dietary lipids and dyslipidemia in chronic kidney disease","volume":"13","author":"Kochan","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.niox.2025.12.003_bib49","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.clnu.2019.02.041","article-title":"Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: systematic review and meta-analysis of randomized controlled trials","volume":"39","author":"Saglimbene","year":"2020","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.niox.2025.12.003_bib50","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4093\/dmj.2023.0067","article-title":"Dyslipidemia in patients with chronic kidney disease: an updated overview","volume":"47","author":"Suh","year":"2023","journal-title":"Diabetes Metab. J"},{"key":"10.1016\/j.niox.2025.12.003_bib51","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1016\/j.jacc.2019.03.513","article-title":"Efficacy and safety of evolocumab in chronic kidney disease in the FOURIER trial","volume":"73","author":"Charytan","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.niox.2025.12.003_bib52","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11883-024-01191-w","article-title":"Increased cardiovascular risk in young patients with CKD and the role of lipid-lowering therapy","volume":"26","author":"Kratky","year":"2024","journal-title":"Curr. Atheroscler. Rep."}],"container-title":["Nitric Oxide"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860325001065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860325001065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T13:09:19Z","timestamp":1771852159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089860325001065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":52,"alternative-id":["S1089860325001065"],"URL":"https:\/\/doi.org\/10.1016\/j.niox.2025.12.003","relation":{},"ISSN":["1089-8603"],"issn-type":[{"value":"1089-8603","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of S-nitroso-l-cysteine in improving cardiorenal function in eNOS-KO CKD mice","name":"articletitle","label":"Article Title"},{"value":"Nitric Oxide","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.niox.2025.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}